Quanterix names Yuri Fesko as chief medical officer

QTRX•2026-09-14

Quanterix names new chief medical officer

Quanterix appointed Dr. Yuri Fesko as chief medical officer to lead medical and clinical strategy across diagnostics, R&D, regulatory, scientific and commercial teams.

Fesko previously served as chief medical officer at Quest Diagnostics, overseeing medical affairs, clinical development, analytics, public health and quality support.

The appointment comes as Quanterix prepares a broader launch of its Lucent AD Complete Alzheimer’s test, with work continuing on an IVD filing.

Quanterix names Yuri Fesko as chief medical officer

Quanterix names new chief medical officer

Related News

Sanofi transfers 20 mature drugs, three plants to Cheplapharm for 26.4% stake

Live Nation report finds 93% of fans prefer real-world experiences over digital

Japan Post Holdings disposes of Aflac shares worth $1.52 million

Dow to join Morgan Stanley Laguna Conference fireside chat

BofA Global Research Sets 12-Month Target for S&P 500 Index at 7800